Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Oral 💊 is the game changer !!!

<< Previous

Bullboard Posts

Next >>

Comment by Padinaon Jan 25, 2021 9:27pm

114 Views

Post# 32382514

RE:RE:RE:RE:RE:Oral 💊 is the game changer !!!

Its anywhere but USAMRIID
How do you even give tablet to mice unless of course u ground the tablet and that would have defeated the aim of the study bcos the dissolution rate will be unknown if tablet is grounded/disentegrated b4 giving the mouse? i would think tablet study should require a primate. With mice, the best form is either nasal or injection

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario